Comorbidity groups as stratified by scores of the HCT-CI, the ACE-27, and the CCI among patients who underwent transplantation at FHCRC and MDACC
| Index/scores . | Comorbidity group . | FHCRC patients, %, n = 177 . | MDACC patients, %, n = 67 . |
|---|---|---|---|
| HCT-CI | |||
| 0 | Low | 51 | 21 |
| 1 to 2 | Intermediate | 28 | 21 |
| 3 or more | High | 21 | 58 |
| ACE-27 | |||
| 0 | Low | 65 | 48 |
| 1 | Intermediate | 26 | 30 |
| 2 or more | High | 9 | 22 |
| CCI | |||
| 0 | Low | 83 | 70 |
| 1 | Intermediate | 11 | 10 |
| 2 or more | High | 6 | 20 |
| Index/scores . | Comorbidity group . | FHCRC patients, %, n = 177 . | MDACC patients, %, n = 67 . |
|---|---|---|---|
| HCT-CI | |||
| 0 | Low | 51 | 21 |
| 1 to 2 | Intermediate | 28 | 21 |
| 3 or more | High | 21 | 58 |
| ACE-27 | |||
| 0 | Low | 65 | 48 |
| 1 | Intermediate | 26 | 30 |
| 2 or more | High | 9 | 22 |
| CCI | |||
| 0 | Low | 83 | 70 |
| 1 | Intermediate | 11 | 10 |
| 2 or more | High | 6 | 20 |
HCT-CI indicates hematopoietic cell transplantation–specific comorbidity index; ACE-27, adult comorbidity evaluation-27; and CCI, Charlson comorbidity index.